Microsoft links with Rx.com, PDX to extend HealthVault data network
FORT WORTH, Texas Pharmacy system provider PDX and its sister company, Rx.com, joined with Microsoft to unveil an online portal for patients who want access to their pharmacy and health records via Microsoft’s password-protected, Web-based data warehouse, HealthVault.
Under the new pact, pharmacies using the Rx.com electronic pharmacy record can export their patients’ prescription history into HealthVault, where patients can access their aggregated prescription data. PDX will serve as a link between the pharmacies it serves and Microsoft’s HealthVault platform.
Meijer, Inc., is the first PDX client to offer that link to its patients, according to PDX.
The move underscores Microsoft’s determination to be a key player in the fast-emerging health information technology revolution. Last week, the company announced a new, separate partnership between HealthVault and Walgreens.
“PDX and Rx.com connecting with HealthVault helps put consumers in control of managing their own care the the care of extended family members,” said David Cerino, general manager of the Consumer Health Solutions Group at Microsoft. “Customers from thousands of pharmacies…will be able to integrate their prescription history into HealthVault, which will provide them with a more complete picture of their health and allow them to make better healthcare decisions.”
Currently, patients can access their prescription history from each individual pharmacy’s Web site. “With the HealthVault integration, patients of pharmacies that aggregate their data in the Rx.com EPR can go to one Web site, Rx.com, to get copies of all their pharmacy data downloaded into their HealthVault user account,” the company reported Tuesday.
Ken Hill Sr., founder and CEO of PDX and Rx.com, said the new agreement with Microsoft “will give our 65 chain pharmacy customers, as well as our independent pharmacies, the ability to integrate client prescription history from a single source into HealthVault at the patient’s request.”
Target gives award to RelayHealth Pharmacy Solutions
ATLANTA Target has named RelayHealth Pharmacy Solutions a recipient of its 2008 “Partner Award of Excellence.” The award was recently presented to RelayHealth at the National Council for Prescription Drug Program’s Annual Conference in Scottsdale, Ariz.
Target annually recognizes vendor partners for their extraordinary passion for performance and dedication to the Target brand. RelayHealth Pharmacy Solutions earned the award by demonstrating innovative leadership, superior business practices and commitment to Target’s core strategies: differentiation, value and reliability.
Notable areas of excellence were RelayHealth’s operational responsiveness and collaborative partnership in creating new services.
“We are proud to partner with [Target] to bring innovative solutions that enhance their operations and clinical services for their valued pharmacy patrons,” said Jeff Felton, president, RelayHealth Pharmacy Solutions. “This award is truly a tribute to the dedication of our entire team and recognizes our long-standing relationship.”
RelayHealth helps improve clinical and financial information management, patient safety and business performance. RelayHealth also provides network and claims processing connectivity services that add value and efficiency to more than 90% of the nation’s retail pharmacies.
Vivus presents results of glucose-lowering investigational drug
NEW ORLEANS An investigational drug for treating lowered blood sugar levels in obese patients who had not developed diabetes, according to results of a phase 3 trial presented Saturday at the American Diabetes Association’s 69th annual scientific sessions.
Drug maker Vivus said the trial of the drug Qnexa showed that while Qnexa lowered blood sugar, patients taking placebo experienced higher blood sugar after 28 weeks of treatment.
“Obesity is the leading cause of Type 2 diabetes,” lead investigator and Weill-Cornell University clinical professor Louis Aronne said in a statement. “Studies have shown that Type 2 diabetes can be treated effectively in most patients with significant weight loss.”